F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Advanced hepatocellular carcinoma

Page 1 of 1 ( 9 items )
<<
1
>>

1	Prognostic value of immune-inflammation and nutritional indices in advanced hepatocellular carcinoma patients receiving immunotherapy with compound Kushen injection 7/14/2025 12:56:06 PM \| Browse: 186 \| Download: 755
2	Integrating ultrasound and serum indicators for evaluating outcomes of targeted immunotherapy in advanced liver cancer 5/15/2025 10:29:01 AM \| Browse: 164 \| Download: 772
3	Factors influencing anxiety and depression in advanced hepatocellular carcinoma patients and their impact on quality of life 4/30/2025 8:58:23 AM \| Browse: 145 \| Download: 807
4	Novel multimodal analgesic regimen for perioperative pain management after hepatic artery infusion chemotherapy in patients with advanced hepatocellular carcinoma 3/29/2025 6:54:17 AM \| Browse: 183 \| Download: 688
5	Advancing treatment strategies: Insights from network meta-analysis of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma 12/12/2024 9:30:49 AM \| Browse: 205 \| Download: 679
6	Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges 9/26/2024 10:17:48 AM \| Browse: 183 \| Download: 673
7	Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma 1/11/2024 5:28:09 AM \| Browse: 436 \| Download: 1376
8	Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma 8/26/2022 9:51:35 AM \| Browse: 581 \| Download: 1461
9	Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up 5/19/2015 5:28:00 PM \| Browse: 1517 \| Download: 1848

Page 1 of 1 ( 9 items )
<<
1
>>

Write to the Help Desk

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.